Engelsk 
Ecolab Life Sciences Opens New State-Of-The-Art Bioprocessing Applications Laboratory in Pennsylvania, US
ST. PAUL, Minn. – May 14, 2025 – Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania.
The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full commercial production. This new development location is well positioned in the Eastern U.S., close to many large pharmaceutical operations and a hub of bioprocessing innovation.
The lab is equipped with high-throughput process development tools and manufacturing scale chromatography columns, enabling biotech firms to receive turnkey support for process development. Large biopharma companies can utilize the applications lab throughout the entire development cycle, from early to late stage and commercialization; including characterizing alternative resins to help reduce manufacturing costs and support with regulatory submissions.
"Our new Bioprocessing Applications Lab marks a significant milestone in our ability to be a global technical partner to our customers around the world," said Jennifer Sorrells, Ph.D., vice president of research and development, Ecolab Life Sciences. "This facility demonstrates our commitment to delivering best-in-class bioprocessing solutions by pairing Ecolab's innovative resin toolbox with deep domain expertise to optimize the purification process. We are dedicated to empowering our customers to accelerate the delivery of life-saving therapies to market."
Biopharma and contract manufacturing organizations are already leveraging Ecolab's Bioprocessing Applications Lab to help accelerate speed and enhance manufacturing efficiencies through lifecycle studies. The lab can initiate studies and deliver results within weeks, facilitating a faster route to market while providing customers with access to raw data and bench-level operations for transparency and collaboration.
The new lab complements Ecolab’s existing European Applications and Research & Development Lab, in Wales, U.K., and is part of the Ecolab Life Sciences Pharma Center of Excellence, a multi-million dollar investment which also includes an interactive learning space, The Xchange customer experience center, and an API (Active Pharmaceutical Ingredient) and excipient manufacturing facility.
Learn more here.
Om Ecolab
Ecolab (NYSE:ECL) er en betrodd partner for millioner av kunder og er en global leder innenfor bærekraft som tilbyr løsninger og tjenester for vann, hygiene og forebygging av infeksjoner som beskytter folk og livsvikte ressurser. Med mer enn hundre år med nyskapning bak seg, har Ecolab årlig omsetning på USD 16 milliarder, sysselsetter rundt 48 000 medarbeidere, og har virksomhet i mer enn 170 landt verden over. Selskapet leverer omfattende vitenskapelig baserte løsninger, datadreven innsikt og tjenester i verdensklasse for å fremme matsikkerhet og trygge miljø, samt optimalisere bruk av vann og energi. Ecolabs nyskapende løsninger forbedrer driftseffektiviteten og bærekraften for kunder ipå markedene for mat, helsevesen, høyteknologi, livsvitenskap, kost og losji og industri. www.ecolab.com
Følg oss på LinkedIn @Ecolab, Instagram @Ecolab_Inc og Facebook @Ecolab.